AI predicting brain cancer relapse is making groundbreaking strides in pediatric oncology, offering new hope in the fight against recurring gliomas.A recent study from Mass General Brigham reveals that an advanced AI tool can analyze a series of brain scans over time, significantly outperforming traditional methods in predicting the likelihood of relapse in young patients.